Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julien Schmidt

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Emerging Infectious Diseases|January 25, 2024
Critically Ill Patients with Visceral Nocardia Infection, France and Belgium, 2004-2023Lucas Khellaf, Virginie Lemiale, Maxens Decavèle, et al.
Cell Metabolism|April 10, 2009
CXC ligand 5 is an adipose-tissue derived factor that links obesity to insulin resistanceCarine Chavey, Gwendal Lazennec, Sylviane Lagarrigue, et al.
Nature Biotechnology|November 16, 2021
Sensitive identification of neoantigens and cognate TCRs in human solid tumorsMarion Arnaud, Johanna Chiffelle, Raphael Genolet, et al.
Journal of Critical Care|January 23, 2025
Cardiogenic shock in patients with active onco-hematological malignancies: A multicenter retrospective studyMickael Lescroart, Hélène Kemp, Olivier Imauven, et al.
Science Advances|June 27, 2025
Engineered CD4 TCR T cells with conserved high-affinity TCRs targeting NY-ESO-1 for advanced cellular therapies in cancerMargaux Saillard, Mara Cenerenti, Patrick Reichenbach, et al.
Nature Communications|May 3, 2020
Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with cancerClélia Coutzac, Jean-Mehdi Jouniaux, Angelo Paci, et al.
Critical Care (London, England)|April 8, 2025
Prognosis of liver abscess in the intensive care unit (POLAIR), a multicentre observational studyMarie Le Goff, Frédéric Martino, Geoffrey Rossi, et al.
Nature Communications|March 17, 2018
Sensitive and frequent identification of high avidity neo-epitope specific CD8 <sup>+</sup> T cells in immunotherapy-naive ovarian cancerSara Bobisse, Raphael Genolet, Annalisa Roberti, et al.
Science Advances|February 27, 2021
Tumor-specific cytolytic CD4 T cells mediate immunity against human cancerAmélie Cachot, Mariia Bilous, Yen-Cheng Liu, et al.
Nature Biotechnology|June 25, 2024
Author Correction: Identification of clinically relevant T cell receptors for personalized T cell therapy using combinatorial algorithmsRémy Pétremand, Johanna Chiffelle, Sara Bobisse, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Emerging Infectious Diseases|January 25, 2024
Critically Ill Patients with Visceral Nocardia Infection, France and Belgium, 2004-2023Lucas Khellaf, Virginie Lemiale, Maxens Decavèle, et al.
Cell Metabolism|April 10, 2009
CXC ligand 5 is an adipose-tissue derived factor that links obesity to insulin resistanceCarine Chavey, Gwendal Lazennec, Sylviane Lagarrigue, et al.
Nature Biotechnology|November 16, 2021
Sensitive identification of neoantigens and cognate TCRs in human solid tumorsMarion Arnaud, Johanna Chiffelle, Raphael Genolet, et al.
Journal of Critical Care|January 23, 2025
Cardiogenic shock in patients with active onco-hematological malignancies: A multicenter retrospective studyMickael Lescroart, Hélène Kemp, Olivier Imauven, et al.
Science Advances|June 27, 2025
Engineered CD4 TCR T cells with conserved high-affinity TCRs targeting NY-ESO-1 for advanced cellular therapies in cancerMargaux Saillard, Mara Cenerenti, Patrick Reichenbach, et al.
Nature Communications|May 3, 2020
Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with cancerClélia Coutzac, Jean-Mehdi Jouniaux, Angelo Paci, et al.
Critical Care (London, England)|April 8, 2025
Prognosis of liver abscess in the intensive care unit (POLAIR), a multicentre observational studyMarie Le Goff, Frédéric Martino, Geoffrey Rossi, et al.
Nature Communications|March 17, 2018
Sensitive and frequent identification of high avidity neo-epitope specific CD8 <sup>+</sup> T cells in immunotherapy-naive ovarian cancerSara Bobisse, Raphael Genolet, Annalisa Roberti, et al.
Science Advances|February 27, 2021
Tumor-specific cytolytic CD4 T cells mediate immunity against human cancerAmélie Cachot, Mariia Bilous, Yen-Cheng Liu, et al.
Nature Biotechnology|June 25, 2024
Author Correction: Identification of clinically relevant T cell receptors for personalized T cell therapy using combinatorial algorithmsRémy Pétremand, Johanna Chiffelle, Sara Bobisse, et al.
Pageof 6